Skip to content
Insider tapeFilings through Fri, Oct 2
Watchlist

Birgit Girshick

CEO at Charles River Laboratories International, Inc. (CRL)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $1.8M

Reported trades

Filed Stock Type Shares Price Value Since
Aug 13SEC CRLCharles River Laboratories International, Inc. Sell Plan 6,500 $279.90 $1.8M +11.0%
  • Sell

    CEO Birgit Girshick sold $1.8M of CRL at $279.90 — pre-scheduled 10b5-1 plan sale.